We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Panel Says Seroquel OK For Teens

Law360 (June 10, 2009, 12:00 AM EDT) -- AstraZeneca PLC antipsychotic Seroquel, which had sales of $800 million in the U.S. in the first quarter of 2009, is acceptably safe and effective for treating schizophrenia in teenagers, as well as treating bipolar mania in kids as young as 10, according to a U.S. Food and Drug Administration panel.

The advisory committee weighed in Wednesday on Seroquel, as well as Eli Lilly and Co.'s Zyprexa and Pfizer Inc.'s Geodon.

In a 17-1 vote, the panel said that Seroquel was effective for treating schizophrenia in pediatric...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.